Efficacy and safety of tofacitinib in Chinese patients with active psoriatic arthritis: a phase 3, randomised, double-blind, placebo-controlled study X Leng, W Lin, S Liu, K Kanik, C Wang, W Wan, Z Jiang, Y Liu, S Liu, ... RMD open 9 (1), e002559, 2023 | 15 | 2023 |